2.17p-0.11 (-4.89%)04 Jul 2025, 16:30
Jump to:
Immupharma PLC Fundamentals
Company Name | Immupharma PLC | Last Updated | 2025-07-04 |
---|---|---|---|
Industry | Biotechnology | Sector | Healthcare |
Shares in Issue | 416.437 m | Market Cap | £8.91 m |
PE Ratio | 0.00 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | -£0.01 | EPS Growth (%) | 0 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0 | Debt Equity Ratio | 0 |
Asset Equity Ratio | -1.7998 | Cash Equity Ratio | -0.4364 |
Quick Ratio | 0.2807 | Current Ratio | 0.58 |
Price To Book Value | 0 | ROCE | 0 |
Immupharma PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
Immupharma PLC Company Financials
Assets | 2024 | 2023 | 2022 |
---|---|---|---|
Tangible Assets | £82,321.00 | £102,075.00 | £389,718.00 |
Intangible Assets | £9,822.00 | £447,571.00 | £473,892.00 |
Investments | 0 | £643,781.00 | £688,350.00 |
Total Fixed Assets | £92,143.00 | £1.38 m | £1.64 m |
Stocks | 0 | 0 | 0 |
Debtors | £189,665.00 | £451,546.00 | £649,401.00 |
Cash & Equivalents | £236,902.00 | £208,481.00 | £667,813.00 |
Other Assets | 0 | £184,785.00 | £83,790.00 |
Total Assets | £977,011.00 | £2.72 m | £3.97 m |
Liabilities | 2024 | 2023 | 2022 |
---|---|---|---|
Creditors within 1 year | £1.52 m | £1.67 m | £1.45 m |
Creditors after 1 year | 0 | 0 | 0 |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | £1.52 m | £1.67 m | £1.45 m |
Net assets | -£542,859.00 | £1.06 m | £2.52 m |
Equity | 2024 | 2023 | 2022 |
---|---|---|---|
Called up share capital | £29.81 m | £29.81 m | £28.98 m |
Share Premium | £29.32 m | £29.32 m | £28.79 m |
Profit / Loss | -£2.78 m | -£3.42 m | -£4.46 m |
Other Equity | -£542,859.00 | £1.06 m | £2.52 m |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | -£542,859.00 | £1.06 m | £2.52 m |
Ratios | 2024 | 2023 | 2022 |
---|---|---|---|
Debt Ratio | 0 | 0 | 0 |
Debt-to-Equity | 0 | 0 | 0 |
Assets / Equity | -1.7998 | -1.7998 | -1.7998 |
Cash / Equity | -0.4364 | -0.4364 | -0.4364 |
EPS | -£0.01 | -£0.01 | -£0.01 |
Cash Flow | 2024 | 2023 | 2022 |
---|---|---|---|
Cash from operating activities | -£1.77 m | -£1.36 m | -£2.35 m |
Cashflow before financing | -£1.27 m | -£642,311.00 | -£799,335.00 |
Increase in Cash | £24,547.00 | -£453,549.00 | -£876,759.00 |
Income | 2024 | 2023 | 2022 |
---|---|---|---|
Turnover | 0 | 0 | 0 |
Cost of sales | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 |
Operating Profit | -£2.68 m | -£3.06 m | -£3.03 m |
Pre-Tax profit | -£2.78 m | -£3.42 m | -£4.46 m |
Immupharma PLC Company Background
Sector | Healthcare |
---|---|
Activities | ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus, a life-threatening autoimmune disease, and other candidates are P140 CIDP and BioAMB Fungal infections. |
Latest Interim Date | 9 Sep 2024 |
Latest Fiscal Year End Date | 19 May 2025 |
Immupharma PLC Directors
Appointed | Name | Position |
---|---|---|
2021-07-30 | Dr. Franco Di Muzio | Non-Executive Director |
2006-03-31 | Mr. Douglas Gordon James Paterson | Non-Executive Director |
2025-05-19 | Mr. Timothy Paul McCarthy | Executive Director,Chairman and Chief Executive Officer |
2021-07-30 | Mr. Dimitri Dimitriou | Executive Director,Chief Executive Officer |
2021-05-24 | Dr. Robert Henri Zimmer | Executive Director,President and Chief Scientific Officer |
2016-05-05 | Mr. Richard Leonard Warr | Executive Director,Chairman |
2016-05-05 | Dr. Ajay Agrawal | Non-Executive Director |
2011-08-09 | Mr. Paddy Hugh Walker-Taylor FCA,MCT | Executive Director,Chief Financial Officer |
2006-03-31 | Mr. Anthony Johnson B.Pharm,MSc | Non-Executive Director |
2023-08-11 | Dr. Sanjeev Pandya | Non-Executive Director,Senior Independent Director |
2021-07-30 | Dr. Stephane Robert George Mery | Non-Executive Director |
2025-05-19 | Dr. Timothy Gary Franklin | Executive Director,Chief Operating Officer |
2025-05-19 | Ms. Lisa Baderoon | Non-Executive Director,Head of Investor Relations |
2025-05-19 | Dr. Robert Reilly Laurence | Non-Executive Director,Senior Independent |
2025-05-19 | Dr. Sebastien R. Goudreau | Non-Executive Director |
Immupharma PLC Contact Details
Company Name | ImmuPharma PLC |
---|---|
Address | One Bartholomew Close, London, EC1A 7BL |
Telephone | +44 2071524080 |
Website | https://www.immupharma.co.uk |
Immupharma PLC Advisors
Stockbroker | Bryan, Garnier & Co Limited |
---|---|
Phone | +44 2073322500 |
Nominated Adviser | Northland Capital Partners |
---|---|
Phone | +44 2038616625 |
Fax | +44 2076005975 |
Stockbroker | Northland Capital Partners |
---|---|
Phone | +44 2038616625 |
Fax | +44 2076005975 |
Registrar | Computershare Investor Services PLC |
---|---|
Phone | +44 3707020003 |
Fax | +44 3707036101 |
Auditor | Nexia Smith & Williamson |
---|---|
Phone | +44 2071314000 |
Fax | +44 2071314001 |
Solicitor | Bircham Dyson Bell |
---|---|
Phone | +44 2072277000 |
Fax | +44 2072223480 |
Bank | Royal Bank of Scotland PLC |
---|
Auditor | Nexia Smith & Williamson Audit Limited |
---|
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Auction Technology Group PLC | 499.00 | 4.39 |
Vodafone Group PLC | 81.62 | 3.00 |
Raspberry Pi Holdings PLC | 482.60 | 2.68 |
Coca-Cola Europacific Partners PLC | 7,130.00 | 2.00 |
Big Yellow Group PLC | 971.00 | 2.00 |
Elementis PLC | 168.80 | 1.81 |
Fallers
Company | Price | % Chg |
---|---|---|
Moonpig Group PLC | 232.00 | -4.13 |
Aston Martin Lagonda Global Holdings PLC | 80.75 | -3.69 |
Trustpilot Group PLC | 230.80 | -3.67 |
Ncc Group PLC | 138.00 | -3.50 |
4Imprint Group PLC | 3,670.00 | -3.42 |
Just Group PLC | 129.02 | -3.28 |